300 related articles for article (PubMed ID: 19621418)
21. CD44 as a Potential Screening Marker for Preliminary Differentiation Between Congenital Dyserythropoietic Anemia Type II and Hereditary Spherocytosis.
Singleton BK; Ahmed M; Green CA; Heimpel H; Woźniak MJ; Ranjha L; Seeney F; Bomford A; Mehta P; Guest A; Mushens R; King MJ
Cytometry B Clin Cytom; 2018 Mar; 94(2):312-326. PubMed ID: 27784127
[TBL] [Abstract][Full Text] [Related]
22. Mutational spectrum in congenital dyserythropoietic anemia type II: identification of 19 novel variants in SEC23B gene.
Russo R; Esposito MR; Asci R; Gambale A; Perrotta S; Ramenghi U; Forni GL; Uygun V; Delaunay J; Iolascon A
Am J Hematol; 2010 Dec; 85(12):915-20. PubMed ID: 20941788
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of genotype and phenotype of SEC23B gene in a family affected with congenital dyserythropoietic anemia type II].
Li D; Li B; Qu S; Cao W; Yang Y; Ma Y; Hou T
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Dec; 34(6):874-878. PubMed ID: 29188620
[TBL] [Abstract][Full Text] [Related]
24. Transduction with BBF2H7/CREB3L2 upregulates SEC23A protein in erythroblasts and partially corrects the hypo-glycosylation phenotype associated with CDAII.
Pellegrin S; Haydn-Smith KL; Hampton-O'Neil LA; Hawley BR; Heesom KJ; Fermo E; Bianchi P; Toye AM
Br J Haematol; 2019 Mar; 184(5):876-881. PubMed ID: 29536501
[No Abstract] [Full Text] [Related]
25. Congenital dyserythropoietic anemia type II: molecular basis and clinical aspects.
Iolascon A; D'Agostaro G; Perrotta S; Izzo P; Tavano R; Miraglia del Giudice B
Haematologica; 1996; 81(6):543-59. PubMed ID: 9009444
[TBL] [Abstract][Full Text] [Related]
26. [Congenital dyserythropoietic anemia type II with novel mutations in SEC23B and HFE2 genes: a Chinese family survey].
Wang L; Liu G; Zhang Q; Cai H; Niu SW; Han B; Nie GJ
Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):704-8. PubMed ID: 23978024
[TBL] [Abstract][Full Text] [Related]
27. Congenital dyserythropoietic anemia type II in a newborn with a novel compound heterozygous mutation in the SEC23B: a case report and review of the literature.
Zheng J; Gao L; Liu H; Xiao P; Lu J; Li J; Wu S; Cheng S; Bian X; Du Z; Kong L; Hu S; Fan J
Int J Hematol; 2024 Feb; 119(2):210-214. PubMed ID: 38127226
[TBL] [Abstract][Full Text] [Related]
28. Development of High-Resolution Melting Curve Analysis for rapid detection of SEC23B gene mutation causing Congenital Dyserythropoietic Anemia type II in Indian population.
Saptarshi AN; Dongerdiye RK; More TA; Kedar PS
Ital J Pediatr; 2023 Jul; 49(1):84. PubMed ID: 37455305
[TBL] [Abstract][Full Text] [Related]
29. Congenital dyserythropoietic anemia type II mimicking hereditary spherocytosis in Indian patient with SEC23B-Y462C mutations.
Kedar P; Parmar V; Devendra R; Gupta V; Warang P; Madkaikar M
Ann Hematol; 2017 Dec; 96(12):2135-2139. PubMed ID: 28879554
[No Abstract] [Full Text] [Related]
30. Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy.
Goede JS; Benz R; Fehr J; Schwarz K; Heimpel H
Ann Hematol; 2006 Sep; 85(9):591-5. PubMed ID: 16767397
[TBL] [Abstract][Full Text] [Related]
31. Heterozygosity of CDAN II (HEMPAS) gene may be detected by the analysis of erythrocyte membrane glycoconjugates from healthy carriers.
Zdebska E; Mendek-Czajkowska E; Ploski R; Woêniewicz B; Koscielak J
Haematologica; 2002 Feb; 87(2):126-30. PubMed ID: 11836161
[TBL] [Abstract][Full Text] [Related]
32. SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II.
King R; Lin Z; Balbin-Cuesta G; Myers G; Friedman A; Zhu G; McGee B; Saunders TL; Kurita R; Nakamura Y; Engel JD; Reddy P; Khoriaty R
Sci Adv; 2021 Nov; 7(48):eabj5293. PubMed ID: 34818036
[TBL] [Abstract][Full Text] [Related]
33. Characteristic phenotypes associated with congenital dyserythropoietic anemia (type II) manifest at different stages of erythropoiesis.
Satchwell TJ; Pellegrin S; Bianchi P; Hawley BR; Gampel A; Mordue KE; Budnik A; Fermo E; Barcellini W; Stephens DJ; van den Akker E; Toye AM
Haematologica; 2013 Nov; 98(11):1788-96. PubMed ID: 23935019
[TBL] [Abstract][Full Text] [Related]
34. Non-canonical role of wild-type SEC23B in the cellular stress response pathway.
Yehia L; Liu D; Fu S; Iyer P; Eng C
Cell Death Dis; 2021 Mar; 12(4):304. PubMed ID: 33753724
[TBL] [Abstract][Full Text] [Related]
35. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome).
Ferguson PJ; Chen S; Tayeh MK; Ochoa L; Leal SM; Pelet A; Munnich A; Lyonnet S; Majeed HA; El-Shanti H
J Med Genet; 2005 Jul; 42(7):551-7. PubMed ID: 15994876
[TBL] [Abstract][Full Text] [Related]
36. Homozygosity mapping reveals founder SEC23B-Y462C mutations in Indian congenital dyserythropoietic anemia type II.
Singleton B; Bansal D; Varma N; Das R; Naseem S; Saikia UN; Malhotra P; Varma S; Marwaha RK; King MJ; Ahmed M
Clin Genet; 2015 Aug; 88(2):195-7. PubMed ID: 25418799
[No Abstract] [Full Text] [Related]
37. Compound heterozygosity for two novel mutations of the SEC23B gene in congenital dyserythropoietic anemia type II.
Chen S; Guo Z; Ye Y; Yang S; Huang G
Int J Hematol; 2021 Sep; 114(3):390-394. PubMed ID: 33914262
[TBL] [Abstract][Full Text] [Related]
38. Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer.
Yehia L; Niazi F; Ni Y; Ngeow J; Sankunny M; Liu Z; Wei W; Mester JL; Keri RA; Zhang B; Eng C
Am J Hum Genet; 2015 Nov; 97(5):661-76. PubMed ID: 26522472
[TBL] [Abstract][Full Text] [Related]
39. ER-to-Golgi transport and SEC23-dependent COPII vesicles regulate T cell alloimmunity.
Kim S; Khoriaty R; Li L; McClune M; Kalfa TA; Wu J; Peltier D; Fujiwara H; Sun Y; Oravecz-Wilson K; King RA; Ginsburg D; Reddy P
J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33463537
[TBL] [Abstract][Full Text] [Related]
40. The congenital dyserythropoieitic anemias: genetics and pathophysiology.
King R; Gallagher PJ; Khoriaty R
Curr Opin Hematol; 2022 May; 29(3):126-136. PubMed ID: 35441598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
